Rock Springs Capital Management LP Infla Rx N.V. Transaction History

Rock Springs Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$3.06 - $51.61 $688,500 - $11.6 Million	-225,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$31.16 - $48.62 $221,236 - $345,202	7,100 Added 3.26%	225,000 $8.5 Million
Q4 2018 Feb 14, 2019	BUY	$23.33 - $36.37 $942,531 - $1.47 Million	40,400 Added 22.76%	217,900 $7.93 Million
Q3 2018 Nov 14, 2018	BUY	$29.34 - $35.0 $5.21 Million - $6.21 Million	177,500 New	177,500 $6.09 Million

13.2M

5.2K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $61M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.